Quick Answer
Genprex, Inc. reported Operating Income Loss of -$15.52 million for the year ending 2025.
- Genprex, Inc. showed an increase of +26.7% in Operating Income Loss from 2024 to 2025.
- This data is from Genprex, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: -$751.3 thousand | Q2 2017: -$1.18 million | Q3 2017: -$715.1 thousand | Q1 2018: -$686.6 thousand | Q2 2018: -$6.04 million | Q3 2018: -$2.20 million | Q1 2019: -$2.17 million | Q2 2019: -$3.70 million | Q3 2019: -$2.38 million | Q1 2020: -$5.58 million | Q2 2020: -$4.38 million | Q3 2020: -$2.78 million | Q1 2021: -$5.31 million | Q2 2021: -$3.99 million | Q3 2021: -$3.44 million | Q1 2022: -$5.31 million | Q2 2022: -$5.77 million | Q3 2022: -$6.17 million | Q1 2023: -$9.26 million | Q2 2023: -$8.04 million | Q3 2023: -$7.79 million | Q1 2024: -$6.00 million | Q2 2024: -$6.52 million | Q3 2024: -$4.32 million | Q1 2025: -$3.97 million | Q2 2025: -$4.68 million | Q3 2025: -$3.35 million.
- Over the full 10 years of available data (2016 to 2025), Genprex, Inc.'s Operating Income Loss has declined by 275.5%.
- Historical annual values: Fiscal year 2025: -$15.52 million | Fiscal year 2024: -$21.17 million | Fiscal year 2023: -$31.06 million | Fiscal year 2022: -$23.83 million | Fiscal year 2021: -$20.67 million | Fiscal year 2020: -$17.96 million | Fiscal year 2019: -$10.68 million | Fiscal year 2018: -$12.36 million | Fiscal year 2017: -$3.31 million | Fiscal year 2016: -$4.13 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: